—August 2014 in Copenhagen, DK
Blood–based biomarkers for optimal screening
of colorectal neoplasia
In the autumn of 2014 we managed to meet
our long-standing desire to host an international symposium
and bring together all the expertise we know of
within the research field.
We succeeded in gathering
all employees within our research nationally
as well as all national and international
research colleagues, collaborators and sparring partners.
The Symposium benefits
- Many of our collegues and partners,
conducting analyzes of single bio-markers or combinations of markers,
presented their results, which revealed that their marker-profiles
are likely to have a significant influence on the development
of future blood-based concepts in screening for colorectal cancer
—maybe even for cancer in general.
- Specific submissions indicated progress opportunities
in the identification of cancer by screening
using expanded combined models
involving single proteins, proteomes, metabolomes
as well as genetic and epigenetic components.
- The concluding debate at the symposium
revealed great interest among the participating
institutions and companies for future collaborations.
- Subsequently, the symposium has led to several
international—both 3-and 4-parties—
contracts signed with Hvidovre Hospital
as one party to such contracts.